An interventional study of Educational Video with Male or Female Narrator in Vaccine Acceptance, Social Acceptance and Acceptance Processes, sponsored by Children's Hospital of Philadelphia. Completed at 2 sites in United States. Open to participants aged 11 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-06-01.
Sponsored by Children's Hospital of Philadelphia · Not applicable, Interventional, and Other
The purpose of this research study is to determine if video-based education will increase HPV vaccination rates among 11 - 17 year olds.
Human Papillomavirus (HPV) is a common sexually transmitted infection that has the potential to cause cancer. The vaccine is recommended because it prevents the HPV infections that most commonly cause cancer. HPV vaccines offer the best protection to girls and boys who receive the complete, three-vaccine series and have time to develop an immune response before being exposed to HPV. However, vaccination rates are low compared to other vaccines for teens.
Results from this study will help us learn why participants do or do not get the HPV vaccination and whether video-based education can help improve vaccination rates
Children's Hospital of Philadelphia is the lead sponsor of 480 studies on the registry; 85 are open to participants now.
Of its 28 completed or terminated interventional studies of FDA-regulated products, 22 (79%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Study participants will receive the HPV Vaccine Information Statement (VIS) which is part of routine care.
Participants will view an educational video about the HPV vaccine with a male or female narrator. Participants will also receive the HPV Vaccine Information Statement (VIS) which is part of routine care.
Other: Educational Video with Male or Female Narrator
Participants will watch an educational video about the quadrivalent HPV vaccine (Gardasil) narrated by either a male or female.
HPV Vaccination Series Initiation
Number of HPV vaccine doses received among study participants
Time frame: 90 days
HPV Vaccine Series Initiation
HPV Vaccine Receipt among study participants
Time frame: 0 days
HPV Vaccine Series Initiation (depending on male versus female narrator)
Difference in rate of HPV vaccine receipt between study participants who viewed a video narrated by a male versus a female
Time frame: 0 days
HPV Vaccine Series Initiation (depending on male versus female narrator)
Difference in number of HPV vaccine doses between study participants who viewed a video narrated by a male versus a female
Time frame: 90 days
HPV Vaccine Awareness
Reported reason for HPV vaccine receipt or deferral
Time frame: 0 days
This study is completed, as verified in May 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Children's Hospital of Philadelphia